Tag: orphan drug exclusivity
2
FebruaryPediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents but blocks generic approvals, creating a powerful regulatory tool that improves children's drug safety.
Recent posts
-
6 Mar 2026
How to Navigate Cruise Ship Medical Centers for Prescriptions
-
31 Jan 2026
Population Pharmacokinetics: How Data Proves Drug Equivalence
-
12 Feb 2026
How Pharmacists Help Patients Take Their Medications Correctly
-
24 Jun 2025
Actoplus Met: Uses, Benefits, and What You Need to Know
-
29 Sep 2025
NPXL vs Alternatives: In‑Depth Comparison Guide